NewsEvents

Your Yourlocation: Home > Nursing cooperation of tiotropium bromide(136310-93-5) inhalation combined with budesonide inhalation therapy for chronic obstructive pulmonary disease

To investigate the effect of tiotropium bromide(136310-93-5) inhalation combined with budesonide inhalation on the treatment of chronic obstructive pulmonary disease. Methods: In the patients with chronic obstructive pulmonary disease treated in our hospital from March 2015 to October 2015, 80 cases were randomly divided into study group and control group, 40 cases in each group. The routine nursing group in the control group and the comprehensive nursing group were observed to observe the quality of life, acute exacerbation rate and self-management compliance of the two groups. Results: The scores of acute exacerbation rate in the study group were significantly lower than those in the control group (P <0.05). The quality of life of the study group was significantly higher than that of the control group (P <0.05). Conclusion: The use of comprehensive nursing care for chronic obstructive pulmonary disease is better, the application of high value.

To investigate the effect of tiotropium bromide(136310-93-5) combined with microwave in the treatment of chronic obstructive pulmonary disease (COPD). Methods: 86 patients with stable COPD from July 2012 to March 2014 were randomly divided into two groups: randomized double-blind (TB-1-A, home-pulsed) treatment of lungs, once / d, 20 min / time; the control group was given inhalation (160 μg / 4.5 μg) 2 times / time, 2 times / d. The treatment time was 6 months, respectively, compared with the two groups before and after treatment of patients with tiotropium bromide (FEV1 / FVC%), 6 min walking distance, dyspnea score and the incidence of pneumonia and adverse reactions were measured. Results: Before and after treatment, the patients in the control group were treated with the treatment group (P <0.05). The patients were treated with forced expiratory volume (FEV1), 1 second forced expiratory volume FEV1 / FVC were (45.87 ± 3.86)% and (52.34 ± 3.68)%, respectively, and the distance from the FEV1 was (1.52 ± 0.11) L and (1.86 ± 0.13) L, respectively (88.0 ± 7.6) m (2.4.0 ± 5.8) m, dyspnea scores were (2.4 ± 0.4) and (1.9 ± 0.3), the differences were statistically significant (t values were 14.60,15.63,18.63,4.96, P <0.05 ); observed (1.53 ± 0.12) L and (1.84 ± 0.11) L, FEV1 / FVC were (46.03 ± 3.26)% and (52.96 ± 3.58)%, 6 min walking distance were (9.0.0 ± 5.6) m and (231.0 ± 6.3) m, respectively, and the scores of dyspnea were (2.3 ± 0.5) and (1.7 ± 0.4), the differences were statistically significant (t = 13.78, 14.76, 12.34, (P <0.05) .There were no significant differences in lung function, 6-min walking distance and dyspnea score between the control group and the observation group(P> 0.05). In the observation group, there were 2 cases of pneumonia (4.65 (6.93%), the difference was statistically significant (x2 = 2.21, P = 0.03). The economic cost of the 6-month control group was (5902 ± 78) / person, (T = 18.70, P = 0.01). Conclusion: The combination of tiotropium bromide(136310-93-5) and microwave treatment of COPD can effectively improve the pulmonary function, clinical symptoms and exercise tolerance of patients. The curative effect may be close to tiotropium combined with budesonide dermotam group, but does not increase the incidence of pneumonia, and the price is low, worthy of clinical use.

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved